English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 62013CB0210
Case C-210/13
Court of Justice
Status: Closed
Court of Justice
Status: Closed
/
DECISION
- Title
- Rješenje predsjednika osmog vijeća Suda od 14. studenoga 2013. Glaxosmithkline Biologicals SA i Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG protiv Comptroller-General of Patents, Designs and Trade Marks. Zahtjev za prethodnu odluku koji je uputio High Court of Justice (England & Wales), Chancery Division. Lijekovi za primjenu kod ljudi – Svjedodžba o dodatnoj zaštiti – Uredba (EZ) br. 469/2009 – Pojam ,aktivnog sastojka’ i ,mješavine aktivnih sastojaka’ – Adjuvans. Predmet C-210/13.
- ECLI identifier
- ECLI:EU:C:2013:762
- Judge-Rapporteur
- Toader
- Type of procedure
- Prethodno pitanje
- Complementary documents:
07/04/2014
- Title
- Rješenje predsjednika osmog vijeća Suda od 14. studenoga 2013. Glaxosmithkline Biologicals SA i Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG protiv Comptroller-General of Patents, Designs and Trade Marks. Zahtjev za prethodnu odluku koji je uputio High Court of Justice (England & Wales), Chancery Division. Lijekovi za primjenu kod ljudi – Svjedodžba o dodatnoj zaštiti – Uredba (EZ) br. 469/2009 – Pojam ,aktivnog sastojka’ i ,mješavine aktivnih sastojaka’ – Adjuvans. Predmet C-210/13.
- ECLI identifier
- ECLI:EU:C:2013:762
- Judge-Rapporteur
- Toader
- Type of procedure
- Prethodno pitanje
14/11/2013